News | Proton Therapy | August 18, 2016

Hitachi Selected for Southeast Asia's First Proton Beam Therapy System

System will be installed at National Cancer Centre Singapore’s brand-new facility scheduled for completion in 2021

Hitachi, proton beam therapy, PBT system, National Cancer Centre Singapore, NCCS, first in Southeast Asia

August 18, 2016 — Hitachi Asia Ltd. and Hitachi Ltd. announced that Hitachi Asia has received an order for a proton beam therapy (PBT) system from the National Cancer Centre Singapore (NCCS), including a 10-year service and maintenance agreement. It will be the first proton beam therapy system in Southeast Asia.

The PBT system planned for the centre will be equipped with Hitachi's spot scanning technology and will have four treatment rooms with rotating gantries as well as a fixed beam room. The system will be housed in NCCS' newly constructed 24-story cancer treatment and research center, projected to complete in 2021.

Proton beam therapy is a cutting-edge cancer treatment that reduces side effects commonly found in conventional radiotherapy. Cancer is the No. 1 cause of death in Singapore(1). With NCCS tending to almost 70 percent of all public-sector institutions' cancer patients in Singapore, the availability of the first PBT system in the country is undoubtedly a milestone in its cancer treatment.

Prof. Soo Khee Chee, director of NCCS said, "NCCS aims to provide the best in cancer care. Proton beam therapy benefits cancer patients as they experience fewer side effects. It will also spur Singapore's medical community to look for new remedies for cancer. We are also excited about the research possibilities that will open up when the facility is established."

In December 2007, Hitachi became the first company in the world to clear the U.S. Food and Drug Administration (FDA) Premarket Notification Special 510(k) for spot scanning irradiation technology with the PBT system. Hitachi then delivered a proton beam therapy system to the largest cancer hospital in the world, the University of Texas MD Anderson Cancer Center (May 2008), followed by Nagoya Proton Therapy Center (February 2013) and the Hokkaido University Hospital Proton Beam Therapy Center (March 2014). In fiscal year 2015, three more sites in the United States utilizing Hitachi's proton beam therapy system have also begun patient treatment. Hitachi was also awarded the contract with Sibley Memorial Hospital, a member of Johns Hopkins Medicine, in June 2015.

The company's proton beam therapy systems have treated more than 10,000 patients to date while achieving over 98 percent clinical availability rates (system uptime). With long-term service together with quality maintenance, Hitachi's proton beam therapy system is globally renowned for its high reliability.

For more information: www.hitachimed.com

Related Content

Varian announced it has received FDA 510(k) clearance for its Ethos therapy, an Adaptive Intelligence solution. Ethos therapy is an artificial intelligence (AI)-driven holistic solution that provides an opportunity to transform cancer care.
News | Image Guided Radiation Therapy (IGRT) | February 11, 2020
February 11, 2020 — Varian announced it has received FDA 510(k) c
The radiation therapy market is projected to grow in through 2026

Image courtesy of Accuray

News | Proton Therapy | February 10, 2020
February 10, 2020 — Amid technological advancement, and notable research and development activities, the global ...
Accuray TomoTherapy total body irradiation
News | Radiation Therapy | February 07, 2020
February 7, 2020 — Accuray Incorporated announced that two new studies demonstrate the benefits of the ...
The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy

An oxygen map image recovered from a mouse undergoing radiation therapy. The luminescent oxygen probe PtG4 is injected during the week of radiation treatment and localizes between the cells of the tumor as illustrated by microscopy (red). Image courtesy of Brian Pogue, PhD

News | Radiation Therapy | February 03, 2020
February 3, 2020 — Oxygen in cancer tumors is known to be a major factor that helps radiation therapy be successful.
IBA ProteusOne proton therapy system
News | Proton Therapy | January 29, 2020
January 29, 2020 — IBA (Ion Beam Applications S.A.) announced that it has signed a contract and received a major down
Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Six of the top 20 radiotherapy stories in 2019 involved proton therapy. This includes two video inetrviews shot during a site visit to the Northwestern Medicine Proton Center in the Chicago suburb of Warrenville, Ill.

Feature | Radiation Oncology | January 03, 2020 | Dave Fornell, Editor
January 3, 2020 — Here is the top 20 pieces of radiation oncology content on the Imaging Technology News (ITN) websit
Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by an AI algorithm from RaySearch and is the subject of the No. 2 video on the list. Deep learning in radiology and radiation oncology.

Artificial intelligence was by far the hottest topic in both radiology and radiation oncology in 2019, and AI is the subject of 8 of the top 2019 ITN videos. This image is a prostate treatment plan created autonomously by a machine learning algorithm from RaySearch and is the subject of the No. 2 video on the list. 

Feature | December 30, 2019
Here are the top 20 best performing videos posted on the Imaging Technology News website (ITN) from the past year, ba
Beamscan MR for ViewRay MRIdian and for Elekta Unity

Beamscan MR for ViewRay MRIdian and for Elekta Unity

News | Radiation Therapy | December 23, 2019
December 23, 2019 — The Beamscan MR motorized 3-D...